{"body":"<p>These guidelines contribute to achieving the Triple Billion targets of 1 billion more people benefitting from universal health coverage, 1 billion more people better protected from health emergencies and 1 billion more people enjoying better health and well-being<em>(4).<\/em> These guidelines are also expected to help meet UNAIDS commitments and the 95-95-95 targets<em>(5).<\/em><\/p>&#13;\n&#13;\n<p>The objectives of these guidelines are:<\/p>&#13;\n&#13;\n<ul><li>to provide updated, evidence-informed clinical recommendations outlining a public health approach to providing ARV drugs for HIV prevention and treatment for all age groups and populations in the context of the continuum of HIV care, with a focus on settings with limited health system capacity and resources;<\/li>&#13;\n\t<li>to provide guidance on key operational and service delivery issues that need to be addressed to increase HIV prevention, testing and treatment access, strengthen the continuum of HIV care and further integrate the provision of ARV drugs into health systems; and<\/li>&#13;\n\t<li>to provide programmatic guidance for decision-makers and planners at the national level on adapting, setting priorities for and implementing the clinical and operational recommendations and monitoring their implementation and impact.<\/li>&#13;\n<\/ul>","title":"1.2 Objectives","nid":469,"vid":1967,"created":1630673786,"changed":1630675344,"field_content_type":{"tid":1,"name":"Content","class":"content"}}